Voyager Pharmaceutical Corp.
News Releases

This part of our web site contains archival information.

Included below are press releases that were created as of the dates listed and that reflected management's views as of such dates. The information contained therein should not be considered current and may not be accurate. Voyager Pharmaceutical assumes no obligation to update the information on the news releases.

7/19/06 - ICAD: Exciting Advances In Alzheimer Therapies — From Pre-Clinical to Post-Marketing

7/17/06 - Novel Approach May Offer New Hope to Women With Alzheimer’s Disease, Study Show

7/13/06 - Voyager Pharmaceutical Corporation Announces the Formation of its Medical and Scientific Advisory Board

5/15/06 - Leuprolide Acetate Stabilizes Cognitive and Functional Decline in Women with Alzheimer's

5/3/06 - Voyager Pharmaceutical Corporation Completes Second Phase II Clinical Study for Alzheimer's Disease

4/18/06 - Voyager Pharmaceutical Corporation to Present at the 9th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy

4/10/06 - Enrollment Passes Midpoint in Voyager Pharmaceutical Corporation’s Phase III Alzheimer's Trial Ahead of Schedul

3/2/06 - Voyager Pharmaceutical Corporation Announces New Board Members

1/16/06 - Joseph DeVeaugh-Geiss, MD., Expands Role as Interim Chief Medical Officer at Voyager Pharmaceutical Corporation

12/27/05 - Voyager Pharmaceutical Corporation Announces Promotion of Key Scientist

12/22/05 - Voyager Pharmaceutical Corporation Announces Progress in Enrollment for Alzheimer's Study

12/13/05 - Voyager Pharmaceutical Corporation Withdraws Initial Public Offering.

12/8/05 - Voyager Pharmaceutical Corporation Announces Revised Terms for IPO.

9/9/05 - Voyager Pharmaceutical Files for Initial Public Offering.

6/20/05 - Newsweek - 7 Ways to Save a Brain - Current Alzheimer's treatments don't slow the underlying disease process. Researchers are now testing an array of new therapies intended to do just that.

3/7/05 - Voyager Pharmaceutical Corp. Appoints Alzheimer's Association President and CEO Sheldon Goldberg to New Post on Senior Management Team

3/2/05 - Business Week - Where VCs Fear To Tread
Angel investors are filling a critical gap by providing early backing for biotechs

2/16/05 - Voyager Pharmaceutical Corporation Completes Phase II Clinical Study For Alzheimer's Disease

2/10/05 - Voyager Pharmaceutical Corporation Announces Key Executive Promotions

2/8/05 - Voyager Pharmaceutical Corp.  Expands Senior Staff To Support Growth Period

1/27/05 - Voyager Pharmaceutical Corp. Achieves Important Clinical Milestone - Company Moves Closer to Late-Stage Development of Novel Implant to Treat Alzheimer's Disease

12/20/04 - DURECT and Voyager Pharmaceutical Announce the Acceptance of DURIN(TM) Investigational New Drug Application and Clinical Protocol by the FDA for the Treatment of Alzheimer's Disease

6/29/04 - The 9th International Conference on Alzheimer's Disease and Related Disorders is presented by the Alzheimer's Association

7/15/03 - Institute explores new treatment for Alzheimer's disease

7/29/02 - DURECT Corporation and Voyager Pharmaceutical Corporation Sign Development and Commercialization Agreement to Develop Treatment for Alzheimer's Disease